The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer

The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer

Novel magnetic-resonance-guided radiotherapy (MRgRT) permits real-time soft-tissue visualization, respiratory-gated delivery with minimal safety margins, and time-consuming daily plan re-optimisation. We report on early clinical outcomes of MRgRT and routine plan re-optimization for large primary re...

Full description

Bibliographic Details
Main Authors:	Shyama U. Tetar, Omar Bohoudi, Suresh Senan, Miguel A. Palacios, Swie S. Oei, Antoinet M. van der Wel, Berend J. Slotman, R. Jeroen A. van Moorselaar, Frank J. Lagerwaard, Anna M. E. Bruynzeel
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	Cancers
Subjects:	MR-guided radiotherapy MRgRT stereotactic ablative radiotherapy stereotactic ablative radiation therapy (SABR) renal cell cancer
Online Access:	https://www.mdpi.com/2072-6694/12/10/2763

Similar Items

Interfractional Geometric Variations and Dosimetric Benefits of Stereotactic MRI Guided Online Adaptive Radiotherapy (SMART) of Prostate Bed after Radical Prostatectomy: Post-Hoc Analysis of a Phase II Trial
by: Minsong Cao, et al.
Published: (2021-06-01)

Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience
by: Sundus Yahya, et al.
Published: (2018-07-01)

Current Understanding of Ablative Radiation Therapy in Hepatocellular Carcinoma
by: Mathew AS, et al.
Published: (2021-06-01)

IMMUNE EFFECTS OF STEREOTACTIC ABLATIVE RADIATION THERAPY IN PATIENTS WITH MALIGNANT TUMORS: LITERATURE REVIEW
by: A. Yu. Zozulya, et al.
Published: (2020-10-01)

Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer
by: Mix M, et al.
Published: (2019-12-01)

Restricted bowel loop contouring: Improving efficiency in radiotherapy contouring for abdomino-pelvic Stereotactic Ablative Radiotherapy (SABR)
by: Eleanor Clarke, et al.
Published: (2020-09-01)

A decision tool for radiographer-led abdominal image-guided stereotactic ablative body radiotherapy – Experience from a single institution
by: Mairead Daly, et al.
Published: (2021-09-01)

Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: One-Year Clinical Results of a Prospective Registry Study
by: Ailleres, N., et al.
Published: (2022)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
by: Murai Taro, et al.
Published: (2012-08-01)

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
by: Robert Olson, et al.
Published: (2018-10-01)

A feasibility study of stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative radiotherapy practice using tomoedge in helical tomotherapy for lung, liver, and spine targets
by: N V. N. Madhusudhana Sresty, et al.
Published: (2021-01-01)

Sensible Introduction of MR-Guided Radiotherapy: A Warm Plea for the RCT
by: Helena M. Verkooijen, et al.
Published: (2021-03-01)

Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE Registry
by: Sanne Nieuwenhuizen, et al.
Published: (2021-08-01)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
by: Bin Qiu, et al.
Published: (2020-08-01)

A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead?
by: Faiez Al-Shafa, et al.
Published: (2019-06-01)

Primary lung sarcoma treated with stereotactic ablative radiotherapy: a case report
by: Yeo SG
Published: (2017-07-01)

Feasibility and Early Clinical Experience of Online Adaptive MR-Guided Radiotherapy of Liver Tumors
by: Paul Rogowski, et al.
Published: (2021-03-01)

Developments in Stereotactic Body Radiotherapy
by: Anoop Haridass
Published: (2018-12-01)

Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions
by: Raphael Jumeau, et al.
Published: (2020-06-01)

Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer
by: Cathryn B. Crockett, et al.
Published: (2021-03-01)

Complications from Stereotactic Body Radiotherapy for Lung Cancer
by: Kylie H. Kang, et al.
Published: (2015-06-01)

STAT-ART: The Promise and Practice of a Rapid Palliative Single Session of MR-Guided Online Adaptive Radiotherapy (ART)
by: Kathryn E. Mittauer, et al.
Published: (2019-10-01)

Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity
by: Christy Goldsmith, et al.
Published: (2018-10-01)

Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer
by: Katrina Woodford, et al.
Published: (2017-10-01)

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial
by: Liang-Cheng Chen, et al.
Published: (2019-03-01)

Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer
by: Shao-Lun Lu, et al.
Published: (2016-08-01)

Effectiveness of individual audio-visual coaching, respiratory modulated stereotactic body radiotherapy for localized hepatocellular carcinoma: Analysis of 29 cases from a single academic radiotherapy center
by: Liang-Cheng Chen, et al.
Published: (2021-01-01)

Online adaptive planning for prostate stereotactic body radiotherapy using a 1.5 Tesla magnetic resonance imaging-guided linear accelerator
by: Jinzhong Yang, et al.
Published: (2021-01-01)

Stereotactic Radiotherapy for Oligometastasis
by: Sotaro Otake, et al.
Published: (2019-01-01)

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
by: Noura Radwan, et al.
Published: (2017-06-01)

The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases
by: Alexander eChi, et al.
Published: (2014-06-01)

Treatment plan quality during online adaptive re-planning
by: Janita E. van Timmeren, et al.
Published: (2020-08-01)

Clinical outcomes of stereotactic magnetic resonance image‐guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis
by: Stephanie M. Yoon, et al.
Published: (2021-09-01)

Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial
by: Luke Nicholls, et al.
Published: (2020-11-01)

Precision Stereotactic Radiotherapy for Spinal Tumors: Mechanism, Efficacy, and Issues
by: Hongqing Zhuang, et al.
Published: (2020-05-01)

Improved respiratory motion tracking through a novel fiducial marker placement guidance system during electromagnetic navigational bronchoscopy (ENB)
by: Hayley Stowe, et al.
Published: (2019-07-01)

Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis
by: Li M, et al.
Published: (2017-06-01)

Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
by: Hanbo Chen, et al.
Published: (2018-08-01)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
by: Julia Malone, BSC, et al.
Published: (2020-11-01)

Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy: The Next Step in the Treatment of Renal Cell Carcinoma
by: Brian Keller, et al.
Published: (2021-05-01)

Cannot write session to /tmp/vufind_sessions/sess_hh2eq7m3ej98er0jii06mfgois